Reuters logo
BRIEF-A1M Pharma: Mitochondrial protective effect of rA1M in preclinical studies
January 4, 2017 / 2:06 PM / 10 months ago

BRIEF-A1M Pharma: Mitochondrial protective effect of rA1M in preclinical studies

Jan 4 (Reuters) - A1M Pharma AB :

* Announces that rA1M shows mitochondrial protective effect, according to preliminary results from preclinical studies conducted in cooperation with NeuroVive Pharmaceutical

Source text: bit.ly/2iI2Qet

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below